Skip to main content
 

CHTI’s Pat Dunn to participate on upcoming Hello Heart webinar: “Addressing Heart Health with Innovation”

CHTI’s Pat Dunn to participate on upcoming Hello Heart webinar: “Addressing Heart Health with Innovation”

Listen and learn as CHTI’s own Pat Dunn participates with members of the Hello Heart team on Valentine’s Day, February 14th!

Description:
Heart disease is both the #1 cause of death and #1 most expensive chronic disease., But with digital therapeutics, employers can offer their members access to innovations in heart health while reducing their healthcare costs. Do you have a heart health strategy in place?

This Valentine’s Day – when we’re all especially focused on matters of the heart – join this panel discussion to learn how to show that you’re devoted to your members with innovative heart health management. Patrick Dunn, the Program Director of the American Heart Association’s (AHA’s) Center for Health Technology & Innovation (CHTI), joins clinical leaders from Hello Heart to discuss:

  • The wide-reaching impact of poor heart health
  • Using digital therapeutics to address member heart health
  • Recent innovations that empower members to take control of their heart health

Register today to learn more about how digital health innovation can help drive better heart health outcomes.

Speakers: 

Patrick Dunn, PhD/MS/FAHA
Program Director
Center for Health Technology & Innovation
American Heart Association
[email protected]

Edo Paz
SVP, Medical Affairs
Hello Heart
[email protected]

Jenn Roberts
VP, Employer Health Strategy
Hello Heart
[email protected]

Date:
February 14, 2023

 

Time:
2–3 pm, ET (11 am –12 pm, PT)

 

Register today to learn more about how digital health innovation can help drive better heart health outcomes.

More News

  • Innovators’ Network Member Cleerly Closes New Round of Funding

  • AHA Innovators’ Network Member Accurkardia receives FDA Breakthrough Device Designation on New Condition Area

  • Alumni AHA Innovators’ Network Member Companies iRhythm and BioIntelliSense Enter Agreement